-- / --
Issue Date
--
Investment/lot
--
Price Range
--
Lot Size
--
IPO Size
N/A
The IPO of Duroflex comprises a fresh issue and an offer for sale. The fresh issue aggregates up to ₹183.60 crores and the offer for sale aggregates up to 22,564,569 equity shares. The total issue size is pegged at TBA. It’s a 100% book-built issue. The price band is TBA. The IPO opens on TBA and closes on TBA.
The listing date is on TBA and the allotment date is TBA. The credit of shares to the Demat account will take place on TBA, while the initiation of refund will be on TBA.
Duroflex is a provider of sleep and comfort solutions in India, with a diversified omni-channel distribution network. It manufactures a wide range of products, including foam, mattresses, sofas, recliners, beds, pillows, accessories and other furnishings.
The company proposes to utilise the IPO proceeds for:
Detail | Information |
---|---|
Upper Price Band | TBA |
Fresh Issue | Up to ₹183.60 crores |
Offer for Sale | Up to 22,564,569 equity shares |
EPS in ₹ for FY 25 | 4.93 |
Application | Lots | Shares | Amount in INR |
---|---|---|---|
Individual Investors (Retail) (Min) | TBA | TBA | TBA |
Individual Investors (Retail) (Max) | TBA | TBA | TBA |
HNI (Min) | TBA | TBA | TBA |
Investor Category | Shares Offered |
---|---|
QIBs | Not less than 75% of the offer size |
Non-institutional Investors | Not more than 15% of the net offer |
Retail Individual Investors | Not more than 10% of the net offer |
The Indian mattress market has evolved significantly from a fragmented, traditional sector dominated by cotton and coir mattresses to a dynamic, innovation-driven industry with diverse product offerings. During the 1960s and 1970s, the industry was largely unbranded with small scale manufacturers producing cotton and coir mattresses. These products were affordable and durable but offered limited comfort and lacked standardisation.
The Indian mattress market has exhibited continuous growth over the years. It has grown at a CAGR of ~6.2% from ₹270 billion in FY2020 to ₹364 billion in FY2025 and is further expected to grow at a CAGR of ~7.7% till FY2030 to reach a market value of ₹527 billion.
Also, the Indian modern mattress market has grown at a CAGR of approximately 8.6%, increasing from ₹108 billion in FY2020 to ₹163 billion in FY2025. Going ahead, the market is projected to grow at a CAGR of around 10.7% to reach ₹271 billion by FY2030.
The reason for the high growth rate of modern mattresses can be attributed to increasing population, rising urbanisation, increase in disposable income of people, increase in health-related issues of the Indian population, rising demand of such mattresses among consumers because of its various health benefits such as better comfort, temperature regulations etc.
Duroflex is a provider of sleep and comfort solutions in India, with a diversified omni-channel distribution network. Its business has a continuing legacy of over 60 years, with its predecessor entity having been established in 1963.
It manufactures a wide range of products, including foam, mattresses, sofas, recliners, beds, pillows, accessories and other furnishings. According to the TKC Report, Duroflex is among the top three largest mattress companies in India, with 8% branded modern mattress market share by value for fiscal 2025.
Company Name | Revenue from Operations (in ₹ crores) | EPS in | NAV Per Equity Share (in ₹) | Return on Net Worth (in %) |
---|---|---|---|---|
Duroflex | 1134.250 | 4.93 | 41.67 | 11.82 |
Sheela Foam | 3439.190 | 8.84 | 278.84 | 3.19 |
Anchor Investor Bidding Date
TBA
IPO Registrar and Book Running Lead Managers
Duroflex manufactures a wide range of products, including foam, mattresses, sofas, recliners, beds, pillows, accessories and other furnishings. The company has developed a ‘house of brands’ architecture in the sleep and comfort solutions space, with each brand catering to different customer segments, allowing it to capture the full spectrum of mattress customers in India.
The flagship brand, Duroflex, offers sleep and comfort solutions across a spectrum of price points encompassing varied customer requirements, and is aimed at more established and health-conscious customers from the economy to luxury segments of the mattress market. The Sleepyhead brand is aimed at younger customers and provides a range of trendy and stylish mattresses and furniture in the mid to premium segments of the mattress market.
The Perfect Rest brand serves value conscious consumers (primarily from Tier 2+ regions in India) in the economy to mid-premium segments of the mattress market with high quality products.
The revenue from operations of Duroflex grew from ₹1057.487 crores in FY 23 to ₹1134.250 crores in FY 25, while its EBITDA margin grew from 5.38% in FY 23 to 8.64% in FY 25. PAT margin grew from (1.46%) in FY 23 to 4.16% in FY 25. Established business with a continuing legacy and a well-diversified, pan-India omnichannel distribution network has helped the company grow over the years.
According to the TKC Report, Duroflex is among the top three largest mattress companies in India, with 8% branded modern mattress market share by value for fiscal 2025. In South India, which has traditionally been its largest geographic market, it’s among the top two players in the branded modern mattress segment with a market share of approximately 20% for fiscal 2025.
The company has a significant presence across all distribution channels. Its network covers 73 COCO stores, with 375 distributors reaching 5,576 general trade stores and major e-commerce platforms, as of June 30, 2025.
Parameter | FY25 | FY24 | FY23 |
---|---|---|---|
Total Income | 1152.949 | 1106.395 | 1070.270 |
Profit / (Loss) Before Tax | 49.179 | 9.500 | (4.492) |
Profit After Tax | NA | NA | NA |
EBITDA | 97.979 | 62.738 | 56.852 |
EPS in ₹ | 4.93 | 1.17 | (1.62) |
Parameter | FY25 | FY24 | FY23 |
---|---|---|---|
Profit / (Loss) Before Tax | 49.179 | 9.500 | (4.492) |
Net Cash Generated from Operating Activities | 108.203 | 47.160 | 70.405 |
Net Cash Generated from/ (used in) Investing Activities | 3.152 | 45.935 | 27.693 |
Net Cash Flow Used in Financing Activities | (36.058) | (155.809) | (17.549) |
Cash and Cash Equivalents at the End of the Year | 102.897 | 27.600 | 90.314 |
1. Visit the Registrar’s Website
2. Check on the National Stock Exchange Website
The National Stock Exchange (NSE) website has an IPO bid verification module. You can use it to check the allotment status of Duroflex IPO. Go to the NSE website and find the 'Invest' tab. Click on 'Verify IPO Bids' under 'Resources & Tools'.
On the NSE IPO bid verification page, enter:
Then click 'Submit' to know the allotment status.
3. Check on the BSE Website
The Bombay Stock Exchange (BSE) also has an IPO allotment status page. Go to the BSE website and find the 'Investors' tab. Under 'Investors', click on 'IPO'. This will take you to the IPO allotment status page. On the BSE IPO page, follow these steps:
To apply for this IPO:
This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Please read the SEBI-prescribed Combined Risk Disclosure Document before investing. Brokerage will not exceed SEBI’s prescribed limit.
You can read more about Duroflex and its IPO from the company’s red herring prospectus (RHP) here.
Duroflex IPO consists of a fresh issue aggregating up ₹183.600 crores and an offer for sale aggregating up to 22,564,569 equity shares.
The exact dates of the IPO are yet to be announced.
Jacob Joseph George is the Chairman and MD of Duroflex.
The lot size of shares in this IPO is yet to be announced.
You can read more about Duroflex and its IPO from the company’s draft red herring prospectus here.